Kinnov Therapeutics
First-in-class therapy for a worldwide market
Menu
Company
R&D
Product KT-110
Partners
News
Contact us
Final approval by ANSM of Phase 2 study of KT-110 on alcohol addiction
←
Emmanuel de RIVOIRE appointed General Manager of KT
Kinnov Therapeutics raised 2.5 M€ for Phase 2 study of KT-110 on alcohol addiction
→